Mass. dentist disciplined for administering Botox
A well-known Massachusetts dentist who was disciplined for unauthorized use of Botox and inadequate sterilization procedures is a compelling reminder that dental practitioners need to
A well-known Massachusetts dentist who was disciplined for unauthorized use of Botox and inadequate sterilization procedures is a compelling reminder that dental practitioners need to
SafeLink Consulting’s new UQ System is a cloud-based application that helps dental labs and dental practices implement and manage quality systems and safety programs online.
Dentsply International has received regulatory approval from the relevant national competition authorities to proceed with the acquisition of Astra Tech, a provider of dental implant
New regulations in New Jersey that will take effect in December may limit dentists’ ability to administer botox injections to their patients, according to a
As part of Sedation Safety Week, DOCS Education has released a comprehensive list of all the U.S. states and Canadian provinces that changed or updated
A small cluster of protesters, carrying tooth-shaped signs with slogans such as “Ban Mercury,” heralded the opening of a two-day meeting today in Washington, DC,
Align Technology has received regulatory approval from the Chinese State Food and Drug Administration to market and sell the Invisalign system as a class II
The Genesis biomimetic implant system from Keystone Dental has received U.S. regulatory clearance, the company announced. The benefits of the Genesis system include the potential
Researchers have discovered that women, female monkeys, and female mice have major similarities when it comes to how bisphenol A (BPA) is metabolized, and they
Louisiana appears to be nearing the finish line in its efforts to establish regulations governing mobile dental clinics providing care in schools across the state.
Washington state is preparing regulations intended to curb the overuse of prescription painkillers, according to an article in the New York Times. The regulations, being
Sanofi-Aventis and Novalar Pharmaceuticals announced that the Marketing Authorization Application (MAA) for OraVerse has been accepted for review by the regulatory agencies of the U.K.,